Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.46 |
| ▸ | TDO2 | P48775 | 4/20 | 0.45 |
| ▸ | GABRP | O00591 | 3/20 | 0.45 |
| ▸ | GABRD | O14764 | 3/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.45 |
| ▸ | GABRE | P78334 | 3/20 | 0.45 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.45 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.45 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.45 |
| ▸ | GABRQ | Q9UN88 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30636673 | 1.00 | KIF11 (0.46) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL29010434 | 0.76 | GABRA1 (0.47) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL2044016 | 0.74 | KIF11 (0.46) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL29378455 | 0.72 | KIF11 (0.71) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL191347 | 0.72 | KIF11 (0.71) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL13563976 | 0.72 | KIF11 (0.78) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL30560782 | 0.71 | KIF11 (0.55) | KIF11TDO2GABRPGABRDGABRA1 | |
| Carbazole SCHEMBL546743 | 0.71 | ALDH1A1 (0.50) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL2050391 | 0.71 | KIF11 (0.55) | KIF11TDO2GABRPGABRDGABRA1 | |
| SCHEMBL4497738 | 0.70 | GABRP (0.51) | KIF11TDO2GABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116854719-A | Boron-containing polycyclic aromatic compounds and uses thereof | 陕西蒲城海泰新材料产业有限责任公司 | 2023-10-10 | — | — | CN | disclosed |
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | DOOSAN CORPORATION (KR) | 2019-03-19 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| WO-2014010810-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | 주식회사 두산 (KR) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | VDAC1, PIEZO1, SLCO4C1 | KIF11 2210/4885TDO2 1707/4885GABRP 1109/4885 |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | VDAC1, ALDH2, VDAC2 | KIF11 2310/4885TDO2 1202/4885GABRP 1653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.